Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 79,239 |
|
|||||
| News | - | ||||||
| Day High | 3.7669 | Low High |
|||||
| Day Low | 3.56 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Acumen Pharmaceuticals Inc | ABOS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.03 | -0.80% | 3.70 | 00:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.74 | 3.56 | 3.7669 | 3.65 | 3.73 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,262 | 79,239 | $ 3.70 | $ 292,850 | - | 1.8101 - 11.3099 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:51:02 | formt | 1,000 | $ 3.70 | USD |
Acumen Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 211.37M | 57.91M | - | 0 | -52.37M | -0.90 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Acumen Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABOS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.60 | 3.92 | 3.315 | 3.62 | 154,094 | 0.10 | 2.78% |
| 1 Month | 3.24 | 3.92 | 3.07 | 3.35 | 199,494 | 0.46 | 14.20% |
| 3 Months | 3.32 | 5.09 | 3.07 | 3.89 | 310,852 | 0.38 | 11.45% |
| 6 Months | 2.23 | 5.09 | 2.19 | 3.51 | 370,227 | 1.47 | 65.92% |
| 1 Year | 5.57 | 11.3099 | 1.8101 | 5.68 | 569,765 | -1.87 | -33.57% |
| 3 Years | 25.07 | 26.98 | 1.8101 | 7.29 | 415,637 | -21.37 | -85.24% |
| 5 Years | 25.07 | 26.98 | 1.8101 | 7.29 | 415,637 | -21.37 | -85.24% |
Acumen Pharmaceuticals Description
| Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer's disease. The company's lead drug candidate, ACU193, is a subclass monoclonal antibody which selectively targets amyloid-beta oligomers. |
